In this large, real-world cohort study, initiation of tirzepatide was associated with a significantly higher risk of osteoporosis or fragility fractures compared with other GLP-1 receptor agonists
If you do, youll be connected with a clinician who can discuss your health goals, review your medical history, assess whether Zepbound is a good fit, and prescribe it if so
In addition, as the use of weight-loss drugs continues to increase, there has been a rise in documented side effects, with gastrointestinal side effects most commonly linked to fatal outcomes
We see a reduction in liver inflammation when patients use these medications for weight loss, Dr
Wegovy has the deeper long-term outcome data, especially the SELECT trial, which shows cardiovascular event reduction in patients with established cardiovascular disease and overweight or obesity